Circadian rhythm disruption and immunometabolic dysregulation in cancer: rethinking chronotherapy in precision oncology: Erratum

The article, “Circadian rhythm disruption and immunometabolic dysregulation in cancer: rethinking chronotherapy in precision oncology”[1], included inaccurate references. The corrected reference list is below: Takahashi, J. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet 18, 164–179 (2017). https://doi.org/10.1038/nrg.2016.150 El-Tanani M, Rabbani SA, Ali AA, et al. Circadian rhythms and cancer: implications for timing in therapy. Discov Oncol. 2024;15(1):767. Published 18 December 2024. doi:10.1007/s12672-024-01643-4 Liu JL, Xu X, Rixiati Y, et al. Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells. Cell Metab. 2024;36(6):1320-1334.e9. doi:10.1016/j.cmet.2024.04.019 Wang C, Zeng Q, Gül ZM, et al. Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy. Cell. 2024;187(11):2690-2702.e17. doi:10.1016/j.cell.2024.04.015 Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12(5):2115-2132. Published 7 February 2022. doi:10.7150/thno.69424 Quist M, van Os M, van Laake LW, Bovenschen N, Crnko S. Integration of circadian rhythms and immunotherapy for enhanced precision in brain cancer treatment. EBioMedicine. 2024;109:105 395. doi:10.1016/j.ebiom.2024.105395 Lee, Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp Mol Med 53, 1529–1538 (2021). https://doi.org/10.1038/s12276-021-00681-0 Agha RA, Mathew G, Rashid R, et al. Transparency in the reporting of artificial intelligence—the TITAN guideline. Prem J Sci 2025;10:100082.